a Safety and Tolerability Study of EP-9001A in Healthy Volunteers
Clinical trial NCT05278611 · UNKNOWN
Trial details
- NCT number
- NCT05278611
- Sponsor
- Chengdu Easton Biopharmaceuticals Co,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-23
- Primary completion
- 2022-09-01
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.